紐約州 的 食道腺癌 臨床試驗
20 項針對 食道腺癌 的研究正在 紐約州 各地點尋找參與者。
紐約州 的城市
- New York City18 項研究
- Queens9 項研究
- Greenburgh5 項研究
- Rochester5 項研究
- The Bronx3 項研究
- New Rochelle3 項研究
- Buffalo3 項研究
官方研究文本（英文）
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
- Northwell Health Imbert Cancer Center, Bay Shore
- Roswell Park Cancer Institute, Buffalo
- Northwell Health Cancer Institute at Huntington, Greenlawn
- 還有 7 項
招募中2/3 期
18 歲及以上 · 所有性別 · 更新於 2026年10月5日 · NCT06203600mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
- New York-Presbyterian/Brooklyn Methodist Hospital, Brooklyn
- The New York Hospital Medical Center of Queens, Flushing
- Glens Falls Hospital, Glens Falls
- 還有 13 項
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年10月2日 · NCT05677490A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
- Northwell Health/ RJ Zuckerberg Cancer Center, Lake Success
- Memorial Sloan Kettering Cancer Center, New York
- Local Institution - 0274, Rochester
招募中2/3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月30日 · NCT07221149Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Memorial Sloan-Kettering Cancer Center, New York
- New York Cancer & Blood Specialists, Shirley
招募中1/2 期
18 歲及以上 · 所有性別 · 更新於 2026年9月30日 · NCT06324357Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
- Memorial Sloan Kettering Cancer Center Pharmacy (IMP ship to address), Long Island City
- Memorial Sloan Kettering Cancer Center Pharmacy (IMP storage location), Long Island City
- Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York
- 還有 2 項
招募中2/3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月28日 · NCT07392892A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- Columbia University Irving Medical Center, New York
招募中1 期
18 歲及以上 · 所有性別 · 更新於 2026年9月28日 · NCT07277413Study of Denikitug (GS-1811) Given Alone or With Nivolumab or Chemotherapy in Adults With Metastatic Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinomas
- New York Oncology Hematology, Albany
- Weill Cornell Medicine - New York Presbyterian Hospital, New York
招募中2 期
18 歲及以上 · 所有性別 · 更新於 2026年9月21日 · NCT07546812A Study of 2141-V11 in People With Esophageal, Gastric, or Gastroesophageal Junction Adenocarcinoma
- Memorial Sloan Kettering at Suffolk-Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering at Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
- 還有 1 項
招募中1/2 期
18 歲及以上 · 所有性別 · 更新於 2026年9月14日 · NCT07818018Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
- Long Island Jewish Medical Center, Manhasset
- Columbia Universtiy, New York
- University of Rochester Medical Center, Rochester
招募中
18 至 89 歲 · 所有性別 · 更新於 2026年9月11日 · NCT05753748Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
- Research Site, New York
- Research Site, New York
- Research Site, New York
- 還有 2 項
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月9日 · NCT07431281A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- NYU Langone Health, New York
- Icahn School of Medicine At Mount Sinai Prime, New York
- Clinical Research Alliance, Inc, Westbury
- 還有 1 項
招募中1/2 期
18 歲及以上 · 所有性別 · 更新於 2026年8月5日 · NCT06330064A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
- START New York, Lake Success
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
- Icahn School of Medicine at Mount Sinai, New York
招募中1 期
18 歲及以上 · 所有性別 · 更新於 2026年7月15日 · NCT06657144A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Babylon
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Brooklyn
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, New Hyde Park
- 還有 7 項
招募中1 期
18 歲及以上 · 所有性別 · 更新於 2026年7月6日 · NCT04389632Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
- Long Island Jewish Medical Center, New Hyde Park
- Weill Cornell Medicine, New York
- University of Rochester, Rochester
招募中
18 至 89 歲 · 所有性別 · 更新於 2026年7月1日 · NCT05530343First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
- Research Site, New York
招募中1 期
18 歲及以上 · 所有性別 · 更新於 2026年6月12日 · NCT07284186Study of Suratadenoturev (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma
- Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York
招募中2 期
18 歲及以上 · 所有性別 · 更新於 2026年4月23日 · NCT06340711Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
- NYU Langone, New York
- Memorial Sloan Kettering Cancer Center, New York
招募中1 期
18 歲及以上 · 所有性別 · 更新於 2026年3月5日 · NCT04900818A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- 還有 1 項
招募中1 期
18 歲及以上 · 所有性別 · 更新於 2026年2月11日 · NCT06623396Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma
- Roswell Park Cancer Institute, Buffalo
招募中2 期
18 歲及以上 · 所有性別 · 更新於 2026年1月2日 · NCT04682158Propranolol in Combination With Pembrolizumab and Standard Chemotherapy for the Treatment of Unresectable Locally Advanced or Metastatic Esophageal or Gastroesophageal Junction Adenocarcinoma
- Roswell Park Cancer Institute, Buffalo
招募中2 期
18 歲及以上 · 所有性別 · 更新於 2025年12月16日 · NCT05651594資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。